CDER: Drugmakers Should Be Prepared to Justify Clinical Trial Exclusions

Drug Industry Daily
A A
The FDA wants IND sponsors to stop the practice of routinely using age limits as exclusion criteria for clinical trials and increase the number of patients with multiple chronic conditions included in drug studies.

To View This Article:

Login

Subscribe To Drug Industry Daily